CSP # - 526, A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)

Trial Profile

CSP # - 526, A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 Nov 2013

At a glance

  • Drugs DITPA (Primary)
  • Indications Heart failure
  • Focus Pharmacodynamics; Therapeutic Use
  • Most Recent Events

    • 25 Jan 2010 Results on DITPA effects on body weight, lipoproteins and bone metabolism markers were presented in the Journal of Clinical Endocrinology and Metabolism.
    • 24 Apr 2008 Status changed from recruiting to terminated, as reported in ClinicalTrials.gov.
    • 19 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top